Home NDC 72572-035 bivalirudin
Product NDC 72572-035
11-digit product format 725720035
Labeler code 72572
Product ID 72572-035_53431803-dc0b-42dc-8766-e17c3dbdf4ea
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name bivalirudin
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Civica, Inc.
Application NDA020873
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2020-12-21
Substance BIVALIRUDIN
Active strength 250 mg/1
Pharmacologic classes Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-08-27 00:01 UTC · source 2025-08-26 excluded product product 72572-035 I Inactivated by FDA excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 72572-035 72572-035-10 I Inactivated by FDA excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020873-001 ANGIOMAX BIVALIRUDIN 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020873-001 AP
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N020873-001 7582727 2028-07-27 Drug product N020873-001 7598343 2028-07-27 Drug product N020873-001 7582727*PED 2029-01-27 Pediatric extension N020873-001 7598343*PED 2029-01-27 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Observed Orange Book patent history# Patent history page 1 of 5 · 168 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N020873-001 7582727 2028-07-27 Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020873-001 7598343 2028-07-27 Drug product caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020873-001 7582727*PED 2029-01-27 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020873-001 7598343*PED 2029-01-27 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020873-001 7582727 2028-07-27 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020873-001 7598343 2028-07-27 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020873-001 7582727*PED 2029-01-27 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020873-001 7598343*PED 2029-01-27 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7582727 2028-07-27 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7598343 2028-07-27 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7582727*PED 2029-01-27 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7598343*PED 2029-01-27 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020873-001 7582727 2028-07-27 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020873-001 7598343 2028-07-27 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020873-001 7582727*PED 2029-01-27 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020873-001 7598343*PED 2029-01-27 Pediatric extension 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7582727 2028-07-27 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7598343 2028-07-27 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7582727*PED 2029-01-27 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7598343*PED 2029-01-27 Pediatric extension fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7582727 2028-07-27 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7598343 2028-07-27 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7582727*PED 2029-01-27 Pediatric extension b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7598343*PED 2029-01-27 Pediatric extension b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7582727 2028-07-27 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7598343 2028-07-27 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7582727*PED 2029-01-27 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7598343*PED 2029-01-27 Pediatric extension 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7582727 2028-07-27 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7598343 2028-07-27 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7582727*PED 2029-01-27 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7598343*PED 2029-01-27 Pediatric extension 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7582727 2028-07-27 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7598343 2028-07-27 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7582727*PED 2029-01-27 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7598343*PED 2029-01-27 Pediatric extension 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7582727 2028-07-27 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7598343 2028-07-27 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7582727*PED 2029-01-27 Pediatric extension d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7598343*PED 2029-01-27 Pediatric extension d8e5a09893c0…
Additional Listing Data#
Finished product Yes
Brand name base bivalirudin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BIVALIRUDIN 250 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination TN9BEX005G Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 308769 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72572-035-01 bivalirudin 1 in 1 VIAL, SINGLE-USE INJECTION, POWDER, LYOPHILIZED, 1 2 72572-035-10 bivalirudin 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72572-035 BIVALIRUDIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CIVICA, INC.] 1 Current NDC, Legacy NDC, 2 package rows 20201221_19a4afc5-151d-4d3c-bfef-48aa8797d695.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 72572-035-01 72572003501 1 in 1 VIAL, SINGLE-USE Historical 72572-035-10 72572003510 10 VIAL, SINGLE-USE in 1 CARTON (72572-035-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (72572-035-01) 2020-12-21 0000-00-00 No No Current